Evidence map›Paper›PMID 42542652›Full record

ArticleRespiratory medicine case reports2026

Quantitative CT monitoring of extracorporeal photopheresis response in chronic lung allograft dysfunction: A retrospective case series.

David M Sanborn, Brian J Bartholmai, Tobias Peikert, Cassandra M Braun, Alexander S Niven, Sadia Z Shah, Kelly M Pennington, Brad K Johnson, Srinivasan Rajagopalan, Jeffrey L Winters and 2 more

Abstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David M SanbornDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
Brian J BartholmaiDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Tobias PeikertDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
Cassandra M BraunDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
Alexander S NivenDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
Sadia Z ShahDepartment of Transplantation, Mayo Clinic Jacksonville, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Kelly M PenningtonDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
Brad K JohnsonWilliam J. von Liebig Center for Transplantation and Regenerative Medicine, Mayo Clinic, Rochester, MN, USA.
Srinivasan RajagopalanDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Jeffrey L WintersDivision of Transfusion Medicine, USA.
Elizabeth A GodbeyDepartment of Laboratory Medicine and Pathology, Mayo Clinic Jacksonville, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Cassie C KennedyDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To explore the feasibility and preliminary behavior of the Computer-Aided Lung Informatics for Pathology Evaluation and Rating (CALIPER) tool in detecting radiologic differences in lung parenchyma of lung transplant recipients undergoing extracorporeal photopheresis (ECP) for chronic lung allograft dysfunction (CLAD). Methods: We performed a retrospective case review on a series of adult lung transplant recipients at Mayo Clinic who had a baseline CT following transplant, underwent ECP for CLAD, and had follow-up CT imaging. Our primary outcome was temporal change in lung parenchymal morphology exemplars assessed by CALIPER. Secondary outcomes included changes in distribution of vascular-related structures, calculated lung volumes, and spirometric indices. Data was analyzed using a linear mixed effects model. Findings: Of 91 eligible recipients with CLAD, 15 were treated with ECP. Following ECP we observed an increase in normal lung tissue (p = 0.038) and a decrease in interstitial lung abnormalities (p = 0.003). There was no significant difference in hyperlucent areas, distribution of pulmonary vascular-related structures, or calculated lung volumes. There was a slight increase in FVC (p < 0.001) after initiation of ECP, but no significant change in FEV Conclusions: Initiation of ECP was associated with favorable parenchymal changes as calculated by CALIPER in this sample of patients.

Indexed as

Chronic rejectionCLADLung transplantPhotopheresisRadiomics

Identifiers

PMID42542652
PMCPMC13427608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.